tirzepatide and type 1 diabetes Read now: The SURPASS-EARLY trial found that starting #tirzepatide early in #type2diabetes led to greater improvements in blood sugar, body weight, waist size than intensified standard care. https://bit.ly/3RWnB8m π Another new retrospective cohort
Description
This happens when the patient has used similar medications like other GLP-1 therapies and has shown they can handle them well
Bolli et al., 2014)
Calculators eliminate arithmetic errors but cannot catch input errors
The healthcare provider must show that the unclassified medication is medically necessary for the treatment of the patients condition
